Literature DB >> 18326709

Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins.

Kenji Sugisaki1, Tomohiko Usui, Nobuhiro Nishiyama, Woo-Dong Jang, Yasuo Yanagi, Satoru Yamagami, Shiro Amano, Kazunori Kataoka.   

Abstract

PURPOSE: To investigate the accumulation of new photosensitizers (PSs), dendrimer porphyrin (DP, free DP), and DP encapsulation into polymeric micelles (DP-micelle) and the efficacy of photodynamic therapy (PDT) in an experimental corneal neovascularization model in mice.
METHODS: Corneal neovascularization was induced by suturing 10-0 nylon 1 mm away from the limbal vessel in C57BL6/J mice. To determine the accumulation of free DP and DP-micelle, 10 mg/kg free DP or DP-micelle was administered by intravenous injection 4 days after suture placement. Mice were killed 1, 4, 24, and 168 hours after the injection of PS. Twenty-four hours after the administration of free DP or DP-micelle, mice were treated with a diode laser of 438-nm wavelength at 10 or 50 J/cm(2). Fluorescein angiography was performed before and 7 days after irradiation, and the area of corneal neovascularization was quantified.
RESULTS: Free DP and DP-micelle accumulated in the neovascularized area 1 hour to 24 hours after administration. Fluorescence of DP was weaker than that of DP-micelle. Neither DP-micelle nor DP could be detected in normal limbal vasculature. In the PDT experiments using PS, mean residual rates of corneal neovascularization were 10.1% in the mice treated with DP-micelle and 21.6% in the mice treated with free DP at 10 J/cm(2) (P < 0.01). At 50 J/cm(2), mean residual rates of corneal neovascularization were 10.6% in the mice treated with DP-micelle and 13.7% in the mice treated with free DP (P > 0.05). Although corneal neovascularization in PDT-treated mice exhibited significant regression compared with the control group, significant energy-related vessel regression with increasing laser energy could not be observed.
CONCLUSIONS: PDT with DP-micelle and free DP can provide efficacious treatment of corneal neovascularization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326709     DOI: 10.1167/iovs.07-0389

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

Review 2.  Clinical correlates of common corneal neovascular diseases: a literature review.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Hamdy Salem; Ahmed E Elkhanany; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 3.  Nanotechnology in corneal neovascularization therapy--a review.

Authors:  Lilian Gonzalez; Raymond J Loza; Kyu-Yeon Han; Suhair Sunoqrot; Christy Cunningham; Patryk Purta; James Drake; Sandeep Jain; Seungpyo Hong; Jin-Hong Chang
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-20       Impact factor: 2.671

4.  Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution.

Authors:  Marco Persico; Anna Maria Santoro; Alessandro D'Urso; Danilo Milardi; Roberto Purrello; Alessandra Cunsolo; Marina Gobbo; Roberto Fattorusso; Donatella Diana; Manuela Stefanelli; Grazia R Tundo; Diego Sbardella; Massimo Coletta; Caterina Fattorusso
Journal:  Biomolecules       Date:  2022-05-24

Review 5.  Controlled ocular drug delivery with nanomicelles.

Authors:  Ravi D Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-02

Review 6.  Shining light on nanotechnology to help repair and regeneration.

Authors:  Asheesh Gupta; Pinar Avci; Magesh Sadasivam; Rakkiyappan Chandran; Nivaldo Parizotto; Daniela Vecchio; Wanessa C M A de Melo; Tianhong Dai; Long Y Chiang; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2012-08-21       Impact factor: 14.227

Review 7.  Novel aspects of corneal angiogenic and lymphangiogenic privilege.

Authors:  David Ellenberg; Dimitri T Azar; Joelle A Hallak; Faisal Tobaigy; Kyu Yeon Han; Sandeep Jain; Zhongjun Zhou; Jin-Hong Chang
Journal:  Prog Retin Eye Res       Date:  2010-01-25       Impact factor: 21.198

Review 8.  Dendrimeric systems and their applications in ocular drug delivery.

Authors:  Burçin Yavuz; Sibel Bozdağ Pehlivan; Nurşen Unlü
Journal:  ScientificWorldJournal       Date:  2013-12-14

Review 9.  Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors:  Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal:  Pharmaceutics       Date:  2018-02-27       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.